EXSCIENTIA PLC's ticker is and the CUSIP is 30223G102. A total of 59 filers reported holding EXSCIENTIA PLC in Q2 2023. The put-call ratio across all filers is 1.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,865,662 | -15.9% | 4,395,058 | +10.2% | 0.78% | -5.5% |
Q2 2023 | $23,618,621 | +11.8% | 3,989,632 | +0.1% | 0.82% | +11.7% |
Q1 2023 | $21,126,971 | -1.8% | 3,986,221 | -1.2% | 0.73% | -10.5% |
Q4 2022 | $21,511,528 | -6.8% | 4,035,934 | +43.6% | 0.82% | -14.9% |
Q3 2022 | $23,079,000 | +0.8% | 2,811,120 | +33.7% | 0.96% | +11.3% |
Q2 2022 | $22,898,000 | -14.6% | 2,102,660 | +13.0% | 0.87% | +5.2% |
Q1 2022 | $26,798,000 | -17.7% | 1,860,960 | +12.9% | 0.82% | -9.2% |
Q4 2021 | $32,568,000 | – | 1,648,154 | – | 0.91% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,590,909 | $13,100,000 | 10.36% |
Nan Fung Group Holdings Ltd | 853,050 | $7,004,000 | 4.47% |
SB Global Advisers Ltd | 5,681,818 | $46,648,000 | 3.43% |
Pivotal bioVenture Partners Investment Advisor LLC | 772,285 | $6,340,000 | 2.32% |
MIC Capital Management UK LLP | 1,542,600 | $12,707,000 | 2.29% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,811,120 | $23,079,000 | 0.96% |
Artal Group S.A. | 550,000 | $4,516,000 | 0.19% |
Triatomic Management LP | 37,156 | $305,000 | 0.18% |
Woodline Partners LP | 1,305,006 | $10,714,000 | 0.15% |
Casdin Capital, LLC | 213,900 | $1,756,000 | 0.12% |